April 26, 2021

AireHealth Appoints Kien Nguyen as Chief Executive Officer 

ORLANDO, Fla. – (April 26, 2021) -- AireHealth, a respiratory digital health company based in the U.S., announced today that its Board of Directors has appointed Kien Nguyen as Chief Executive Officer and a member of the AireHealth Board of Directors effective immediately.  Mr. Nguyen is a proven medical device and technology leader with a distinguished track record of product innovation, market development and commercialization.  His career spans nearly three decades leading global teams within medical device and life sciences industries for both start-up and Fortune 500 companies, most recently serving as Chief Commercial Officer at Progenerative Medical.   Mr. Nguyen has also received multiple advanced degrees including a Master of Business Administration from Columbia University and a Doctorate in Neuroscience from the University of Colorado. 

 

“Kien is absolutely the right person to lead AireHealth as we enter this next phase of innovation and growth,” said Stacie Ruth, co-founder and Board Director. “Kien’s ability to translate technologies into solutions with high market value and his deep commercialization expertise will accelerate the execution of AireHealth’s mission to improve the lives of millions of people living with chronic lung disease.”

 

AireHealth recently received 510(k) clearance for a connected nebulizer from the FDA to address the growing challenges in chronic respiratory illness that cost more than $130 billion per year and are the cause of nearly 50 deaths per 100,000 people.  The portable, connected AireHealth nebulizer is part of a comprehensive digital health platform designed to track medication adherence, symptoms, and behaviors to enable earlier clinician intervention and reduce unnecessary hospitalization. 

 

“I am honored to have been chosen by AireHealth’s board of directors to lead the company,” said Mr. Nguyen.  “AireHealth is truly revolutionizing respiratory care for people living with chronic respiratory illness and their care teams.  My primary focus will be to work with the board and a talented , passionate leadership team to execute on the strategy and vision to bring meaningful respiratory care innovation to market faster.”

 

Learn more about AireHealth and how their digital solution can support chronic care management and remote patient monitoring programs for healthcare providers. 

 

+++

 

About AireHealth

AireHealth is an innovative digital health company empowering and improving healthy living through affordable treatments, symptom tracking and early detection of respiratory conditions. With strong IP and clinically validated products in our pipeline, the company enables more proactive care and early interventions to improve outcomes and reduce costs.

The company provides monitored drug delivery through its FDA cleared Class II portable nebulizer, designed to deliver medicine directly to a patient’s lungs where it is most effective. AireHealth’s digital platform allows for earlier detection of respiratory decline through connected devices, the MyAirHealth diary companion app, and provider portal.  The result is that patients not only take a more proactive approach to managing their respiratory care but enables faster clinical intervention and fewer hospitalizations, which helps achieve the goal of improving treatment outcomes and lowering costs. For more information, please visit Aire.Health

Media Contact

AireHealth

Cara Collins

cara.collins@aire.health

574-376-5528

 

March 29, 2021

AireHealth and LucidAct Health Partner in Connecting In-Home Chronic Respiratory Patients with their Provider Care Teams 

LucidAct Health, the leading care coordination platform for virtual care, is pleased to announce integration of their LucidAct Provider Portal with AireHealth’s digital health solution to support remote management of chronic obstructive pulmonary disease (COPD) and other chronic respiratory conditions.

As of January 2021, the Centers for Medicare & Medicaid Services (CMS) has approved over 56 hospitals for its hospital-care-at-home model, which studies have shown to improve outcomes and lower cost, with the added benefit of patients being able to recover in the comfort of their homes. The CMS has stated that with proper monitoring, more than 60 conditions including congestive heart failure (CHF), COPD, and pneumonia can be treated in home settings.

Annually, delayed diagnosis and treatment, poor adherence, and preventable hospitalization contribute to over $130B of unnecessary costs.  Further, respiratory conditions such as Asthma, COPD, respiratory viruses, pneumonia, and cystic fibrosis account for 49.2 deaths per 100,000.

The AireHealth digital health solution includes an FDA-cleared connected portable nebulizer and diary companion app with the following features:

  • Lightweight and quiet portable design to empower people with COPD and other chronic respiratory conditions to stay connected with care teams and live their life on-the-go

  • MyAireHealth diary companion app enables care teams to monitor data for treatment adherence and actionable symptoms to proactively identify and triage their high-risk respiratory patients

  • Bluetooth wireless data transmission to LucidAct, which in turn integrates with the provider’s EMR to support clinical decision-making, helping to reduce unnecessary hospital readmissions

airhealth release dash smaller logo.png



The AireHealth-LucidAct chronic respiratory RPM (Remote Patient Monitoring) solution combines the AireHealth portable nebulizer and MyAireHealth companion app with the LucidAct Provider Portal to support the following use cases: 

  • Enhancing a healthcare provider’s new or existing chronic respiratory management program with remote monitoring to help close gaps in care

  • Monitoring patients who are vulnerable to COVID-19, such as people with COPD and chronic asthma, for COVID-19 symptoms in their homes

  • Adding remote monitoring capability to a health system’s post-acute and virtual care programs to monitor nebulizer medication adherence and proactively triage high-risk respiratory patients

  • Implementing chronic care management (CCM) program for COPD and Asthma patients in rural settings

     

LucidAct Health’s care coordination platform relays AireHealth’s in-home treatment data to the providers’’ EMR system.  Beyond data transmission, LucidAct enables order automation, smart SMS for patient engagement, advanced data analytics and notification of anomalies, no-code triage workflow customization, and insurance billing automation. 

 

About LucidAct Health (www.lucidact.com)  :

LucidAct Health is the next generation provider portal for virtual care delivery. The easiest way to connect hundreds of  in-home medical devices via APIs, mobilizing LucidAct’s network of nurses, care coordinators, and health coaches via workflow automation to delivery faster care like never before.

Contact gracechen@lucidact.com for more information about how LucidAct provider portal can power up your virtual care delivery faster and most cost effectively.

 

About AireHealth (www.aire.health)

AireHealth is an innovative digital health company empowering and improving healthy living through affordable treatments, symptom tracking and early detection of respiratory conditions. With strong IP and clinically validated products in our pipeline, AireHealth enables more proactive care and early interventions to improve outcomes and reduce costs.  For more information.

Contact jan.marti@aire.health for more information about partnering opportunities and to discuss how the AireHealth digital health solution can improve medication adherence and engagement with your COPD and other chronic respiratory patients.

 ——

For more information on the Acute Hospital Care at Home program, please visit the CMS web page: https://www.cms.gov/newsroom/press-releases/cms-announces-comprehensive-strategy-enhance-hospital-capacity-amid-covid-19-surge

 

 

 

      

AIREHEALTH BREATHES EASIER WITH FDA 510(k) CLEARANCE OF CONNECTED NEBULIZER
December 7, 2020
By: Annette Boyle - BioWorld MedTech

 

Airehealth Inc.'s management took a deep breath on hearing that the company's Vitalmed nebulizer received U.S. FDA 510(k) clearance after waiting nearly 11 months. The portable, electronic, vibrating mesh nebulizer will connect to the Orlando, Fla.-based company's diary companion app early next year as part of an integrated suite of products designed to help individuals with chronic respiratory issues track symptoms and better manage their care.

“Consumers facing chronic respiratory issues require care, resources and tools that integrate with their day-to-day lives, which is why the development of a connected platform to comprehensively address their needs is so vital,” said Rebecca Shanahan, Airehealth’s interim CEO. “Airehealth is pleased to have received 510(k) clearance of our connected nebulizer from the FDA, which will support the creation of an overall ecosystem of connected solutions to treat patients with respiratory conditions.”

READ MORE

 

TRANSFORMING THE HEALTHCARE INDUSTRY WITH PROJECT HEALTHCARE 2020
August 5, 2020
By: Nashville Entrepreneur Center

This week, we are honored to introduce you to the 31 teams joining Project Healthcare 2020, Nashville’s top healthcare accelerator-level program. These amazing teams from around the country were chosen from a highly competitive applicant pool to receive resources and support from the best-of-the-best in Nashville's healthcare ecosystem, including The Nashville Health Care Council, Amsurg, Carefluence, LaunchTN, and Burr & Foreman LLP.

“Through listening closely to the business community, investors and entrepreneurs, it became clear that we all need to work closely to help Nashville be the best place to start and grow a business,” said CEO Jane Allen. “We were amazed with the quality companies and entrepreneurs which made this a highly competitive process.” 

READ MORE

 

StartUpHealth_Logo

THESE FOUNDERS ARE USING A SMART NEBULIZERS TO HELP 100 MILLION PEOPLE BATTLING RESPIRATORY ILLNESS
August 4, 2020
By: StartUp Health

AireHealth CEO & Founder Stacie Ruth and Head of Innovation Nirinjan Yee have built a game-changing solution for at-home respiratory care, providing precise detection and tracking of lung disease amid COVID-19 and beyond.

When COVID-19 hit, AireHealth looked for ways to accelerate through the economic downturn through a partnership. In June, AireHealth acquired BreathResearch in a merger that was designed to help build the industry’s first virtual care platform for respiratory illness. The partnership between AireHealth and BreathResearch is enabling the company to save the lungs and improve the quality of life for those with respiratory conditions on a larger scale.

READ AND WATCH MORE

TO MITIGATE AND TRACK COVID-19, ENTREPRENEURS PUSH TO DEVELOP TOOLS
July 15, 2020
By: David M. Ewalt - The Wall Street Journal

If necessity is the mother of invention, a pandemic is a powerful fertility drug. That is evident in the current coronavirus crisis, which has inspired researchers and entrepreneurs to accelerate the development of tools and technologies that might be useful in containing the virus or mitigating its effects.

BreathResearch of Walnut Creek, Calif., is developing a system that would allow doctors to detect and track the progression of respiratory disease by recording and analyzing the sound of a patient’s breathing.

In early June, BreathResearch agreed to merge with AireHealth Inc., a health company focused on respiratory diseases.

READ MORE

AireHealth_Medgadget
A VIRTUAL CARE PLATFORM FOR RESPIRATORY ILLNESS:
INTERVIEW WITH STACIE RUTH, CEO OF AIREHEALTH
July 2, 2020
By: Conn Hastings - Medgadget 

Recently, AireHealth announced a merger with BreathResearch, a respiratory healthcare company based in Silicon Valley that specializes in detection and monitoring of respiratory diseases. The company has developed a portable spirometer that can be used to measure lung health. The technology involves analyzing breathing sounds and lung flow volumes using AI and machine learning to recognize changes in a respiratory condition.

This technology will be merged with that of AireHealth to form VitalBreath, a virtual care platform for respiratory illness. The system encompasses disease monitoring, including a lung health score based on 35 different biomarkers, drug delivery, and patient apps that aim to increase patient engagement and medication adherence.

Medgadget had the opportunity to talk to Stacie Ruth, AireHealth Co-Founder and CEO, about this technology.

READ MORE
AIREHEALTH ACQUIRES BREATHRESEARCH TO FLESH OUT IT'S DIGITAL RESPIRATORY HEALTH PLATFORM
June 8, 2020
By: Dave Muorio - MobiHealthNews

AireHealth, maker of an FDA-cleared portable nebulizer that pairs with a smartphone app for remote monitoring, announced Friday the acquisition of fellow respiratory health company BreathResearch. Financial terms of the deal were not disclosed.

AireHealth already looks to set itself apart with patient-facing digital features and adherence tracking. The new combined offering, VitalBreath powered by BreathResearch, appears to be strengthening the virtual care platform's capabilities so that it can support early detection of respiratory decline.

VitalBreath powered by BreathResearch will support a patient app, adherence tracking and data-analysis capabilities focused on detecting early respiratory decline.

READ MORE




AIREHEALTH MAKES HEALTHLINE'S BEST ASTHMA BLOGS OF 2020
May 15, 2020

Each year, Healthline looks for asthma-focused online resources that offer accurate medical information, insight, and a sense of community to those who need it.

AireHealth is proud to be selected as one of Healthline's Best Asthma Blogs of 2020. Each blog was selected based on the quality of content, the consistency in posts, and engagement with its community.

READ MORE



ORLANDO COMPANY'S PORTABLE NEBULIZER MAY ENHANCE COVID TREATMENT
April 3, 2020
By: Justin Braun - Orlando Economic Partnership

 

Orlando startup AireHealth, based in the University of Central Florida (UCF) Research Park Incubator, has a portable nebulizer that uses a proprietary delivery mechanism to significantly enhance the delivery of drugs for lung related treatments and therapies.

That’s why on March 30, AireHealth announced it was eager to help support the national effort to stem the impacts of the novel Coronavirus, putting out a call for collaborators to help apply the firm’s technology to help coronavirus patients.

HOW THESE 4 LOCAL TECH FIRMS & MANUFACTURERS ARE HELPING THE STRESSED HEALTH CARE SYSTEM 
April 3, 2020
By: Alex Soderstrom - Orlando Business Journal



Autonomous vehicles and 3-D printers are just some of the technologies 
local companies are deploying to help address the squeeze the coronavirus pandemic has placed on the nation's health care system. 

The virus, which had infected more than 1.06 million people worldwide and 9,585 people in Florida as of April 3, has stressed health care systems around the globe. It’s created a demand for medical supplies, especially masks and ventilators. It’s also caused companies around the world — including several in Central Florida — to shift their businesses and produce medical equipment.

While many companies are reeling as the pandemic forces businesses to shutter and the economy to slow, other firms are seeing a new use for their products and equipment. That includes medical tech firm AireHealth Inc., CEO Stacie Ruth told Orlando Business Journal. “When there’s something this big, it creates as much opportunity as it does a crisis.” 

READ MORE

 

Business I4 Logo
UP CLOSE WITH STACIE RUTH
APRIL 2020
By: Meaghan Branham - i4 Business Magazine
 
 

   As the daughter of two business owners, AireHealth CEO and Co-Founder Stacie Ruth knew she wanted to make her mark on the world of business in her own way. Once she found a passion for health care, she knew the business side of the industry would be her calling and soon zeroed in on the production and commercialization of medical products. With the creation of the AireHealth connected nebulizer and Asthma App, Ruth hopes to do the same with her own product. Here, she discusses how and why she founded AireHealth and how tech changes the landscape for sustainable health care.

READ MORE

 

University of Central Florida Business Incubation Program Badge

AIREHEALTH CHOSEN FOR INAUGURAL GUIDEWELL HEALTH TECH ACCELERATOR
June 20, 2019
By: The University of Central Florida
 
 
AireHealth, the recent winner of Rise of the Rest, has been chosen to participate in a new program from GuideWell Innovation designed to help women-founded health care technology companies accelerate their growth.
The firm was one of just five companies from the entire Southeast U.S. and the only one based in Orlando...
 
 
Black Background
GUIDEWELL INNOVATION SELECTS SIZE WOMEN-FUNDED HEALTH TECH COMPANIES FOR SUMMER SCALE-UP ACCELERATOR COHORT
 
June 17, 2019
By: Florida Trend
 
“The GuideWell Scale-Up Accelerator is an eight-week technology accelerator program focused on “Scale-Up” health technology or medical device companies. This cohort is dedicated to companies with women founders that are headquartered in the southeastern U.S.”
 
 
 
RISE OF THE REST: FOSTERING GROWTH REVOLUTION FOR STARTUPS
July, 2019
By: Justin Braun - i4 Business Magazine
 
"Medical technology developed right here in Central Florida is about to disrupt the billion-dollar respiratory care device market. Startup company AireHealth has created a connected nebulizer with the potential to provide patient care and treatment…"
 
 
 
Orlando Business Journal Badge

3 LOCAL WOMEN'S BIOTECH FIRMS CHOSEN FOR 2 NEW ACCELERATOR PROGRAMS 
July 1, 2019
By: Malak Saleh - Orlando Business Journal
 
Three Orlando firms were chosen among 11 from across the Southeast to participate in GuideWell Innovation's two new business accelerator programs.
GuideWell Innovation, a subsidiary of GuideWell Mutual Holding Corp., partnered with nationally recognized accelerator Springboard Enterprises to choose 11 health tech companies founded by women to participate in two new accelerator programs: Scale-Up and Emerging Health Tech...